Basic Information
Oncorena AB is a Swedish pharmaceutical company with the mission of developing breakthrough treatments for advanced kidney cancer (metastatic renal cell carcinoma), aiming to confirm the potent antitumor activity and other clinical benefits of Orellanine in patients with advanced kidney cancer. Oncorena is developing a potentially curative therapy for advanced kidney cancer based on Orellanine.